|
1
|
Roodman GD: Mechanisms of bone metastasis.
N Engl J Med. 350:1655–1664. 2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ferreira AR, Abrunhosa-Branquinho A, Jorge
M, Costa L and Vaz-Luís I: Bone metastases. In: International
Manual of Oncology Practice: (iMOP)-Principles of Medical Oncology.
de Mello RA, Tavares Á and Mountzios G (eds). Springer
International Publishing, Cham, pp867-889, 2015.
|
|
3
|
Bollen L, Dijkstra SPD, Bartels R, de
Graeff A, Poelma DLH, Brouwer T, Algra PR, Kuijlen JMA, Minnema MC,
Nijboer C, et al: Clinical management of spinal metastases-The
Dutch national guideline. Eur J Cancer. 104:81–90. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yang HL, Sun ZY, Wu GZ, Chen KW, Gu Y and
Qian ZL: Do vertebroplasty and kyphoplasty have an antitumoral
effect? Med Hypotheses. 76:145–146. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
O'Toole GC and Boland P: Metastatic bone
cancer pain: Etiology and treatment options. Curr Pain Headache
Rep. 10:288–292. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang PL, He XJ, Li HP, Zang QJ and Wang
GY: Image-guided minimally invasive percutaneous treatment of
spinal metastasis. Exp Ther Med. 13:705–709. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murphy KJ, Nwankwo IJ and Gailloud P:
Percutaneous vertebroplasty in the treatment of blastic vertebral
column metastasis from breast cancer. J Vasc Interv Radiol.
18:321–323. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang Z, Tan J, Zhao R, Wang J, Sun H, Wang
X, Xu L, Jiang H and Zhang J: Clinical investigations on the spinal
osteoblastic metastasis treated by combination of percutaneous
vertebroplasty and 125I seeds implantation versus radiotherapy.
Cancer Biother Radiopharm. 28:58–64. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chih YP, Wu WT, Lin CL, Jou HJ, Huang YH,
Chen LC and Chou LW: Vertebral compression fracture related to
pancreatic cancer with osteoblastic metastasis: A case report and
literature review. Medicine (Baltimore). 95(e2670)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tian QH, Sun XQ, Lu YY, Wang T, Wu CG, Li
MH and Cheng YS: Percutaneous vertebroplasty for palliative
treatment of painful osteoblastic spinal metastases: A
single-center experience. J Vasc Interv Radiol. 27:1420–1424.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McCormack HM, Horne DJ and Sheather S:
Clinical applications of visual analogue scales: A critical review.
Psychol Med. 18:1007–1019. 1988.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chow E, Hird A, Velikova G, Johnson C,
Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, et al:
The European organisation for research and treatment of cancer
quality of life questionnaire for patients with bone metastases:
The EORTC QLQ-BM22. Eur J Cancer. 45:1146–1152. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Deramond H, Depriester C, Galibert P and
Le Gars D: Percutaneous vertebroplasty with polymethylmethacrylate.
Technique, indications, and results. Radiol Clin North Am.
36:533–546. 1998.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mansoorinasab M and Abdolhoseinpour H: A
review and update of vertebral fractures due to metastatic tumors
of various sites to the spine: Percutaneous vertebroplasty. Interv
Med Appl Sci. 10:1–6. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
McGraw JK, Cardella J, Barr JD, Mathis JM,
Sanchez O, Schwartzberg MS, Swan TL and Sacks D: SIR Standards of
Practice Committee. Society of Interventional radiology quality
improvement guidelines for percutaneous vertebroplasty. J Vasc
Interv Radiol. 14:827–831. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Helmberger T, Bohndorf K, Hierholzer J,
Noldge G and Vorwerk D: German Radiological Society. Guidelines of
the german radiological society for percutaneous vertebroplasty.
Radiologe. 43:703–708. 2003.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
17
|
Quinn RH, Randall RL, Benevenia J, Berven
SH and Raskin KA: Contemporary management of metastatic bone
disease: Tips and tools of the trade for general practitioners. J
Bone Joint Surg Am. 95:1887–1895. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dushyanthen S, Cossigny DA and Quan GM:
The osteoblastic and osteoclastic interactions in spinal metastases
secondary to prostate cancer. Cancer Growth Metastasis. 6:61–80.
2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ortiz A and Lin SH: Osteolytic and
osteoblastic bone metastases: Two extremes of the same spectrum?
Recent Results Cancer Res. 192:225–233. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guise TA, Yin JJ and Mohammad KS: Role of
endothelin-1 in osteoblastic bone metastases. Cancer. 97 (Suppl
3):S779–S784. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kasperk CH, Börcsök I, Schairer HU,
Schneider U, Nawroth PP, Niethard FU and Ziegler R: Endothelin-1 is
a potent regulator of human bone cell metabolism in vitro. Calcif
Tissue Int. 60:368–374. 1997.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Johnson RW and Suva LJ: Hallmarks of bone
metastasis. Calcif Tissue Int. 102:141–151. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yi B, Williams PJ, Niewolna M, Wang Y and
Yoneda T: Tumor-derived platelet-derived growth factor-BB plays a
critical role in osteosclerotic bone metastasis in an animal model
of human breast cancer. Cancer Res. 62:917–923. 2002.PubMed/NCBI
|
|
24
|
Achbarou A, Kaiser S, Tremblay G,
Ste-Marie LG, Brodt P, Goltzman D and Rabbani SA: Urokinase
overproduction results in increased skeletal metastasis by prostate
cancer cells in vivo. Cancer Res. 54:2372–2377. 1994.PubMed/NCBI
|
|
25
|
Cramer SD, Chen Z and Peehl DM: Prostate
specific antigen cleaves parathyroid hormone-related protein in the
PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation
in mouse osteoblasts. J Urol. 156:526–531. 1996.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Maeda H, Koizumi M, Yoshimura K, Yamauchi
T, Kawai T and Ogata E: Correlation between bone metabolic markers
and bone scan in prostatic cancer. J Urol. 157:539–543.
1997.PubMed/NCBI
|
|
27
|
Diel IJ, Solomayer EF, Costa SD, Gollan C,
Goerner R, Wallwiener D, Kaufmann M and Bastert G: Reduction in new
metastases in breast cancer with adjuvant clodronate treatment. N
Engl J Med. 339:357–363. 1998.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Saad F, Gleason DM, Murray R, Tchekmedyian
S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA and Chen B:
Zoledronic Acid Prostate Cancer Study Group. A randomized,
placebo-controlled trial of zoledronic acid in patients with
hormone-refractory metastatic prostate carcinoma. J Natl Cancer
Inst. 94:1458–1468. 2002.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu SF, Adams B, Yu XC and Xu M: Denosumab
and giant cell tumour of bone-a review and future management
considerations. Curr Oncol. 20:e442–e447. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sousa S and Clézardin P: Bone-targeted
therapies in cancer-induced bone disease. Calcif Tissue Int.
102:227–250. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dorff TB and Agarwal N: Bone-targeted
therapies to reduce skeletal morbidity in prostate cancer. Asian J
Androl. 20:215–220. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
McClung MR, Brown JP, Diez-Perez A, Resch
H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG,
Zanchetta JR, et al: Effects of 24 months of treatment with
romosozumab followed by 12 months of denosumab or placebo in
postmenopausal women with low bone mineral density: A randomized,
double-blind, phase 2, parallel group study. J Bone Miner Res.
33:1397–1406. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tekin SB, Karslı B, Büyükbebeci O, Demir
İH, Gökalp AY and Kılınçoğlu V: How do vertebroplasty and
kyphoplasty affect the quality of life of patients with multiple
myeloma spinal metastasis? Eur J Orthop Surg Traumatol.
30:1447–1451. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Qi L, Li C, Wang N, Lian H, Lian M, He B
and Bao G: Efficacy of percutaneous vertebroplasty treatment of
spinal tumors: A meta-analysis. Medicine (Baltimore).
97(e9575)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Health Quality Ontario. Vertebral
augmentation involving vertebroplasty or kyphoplasty for
cancer-related vertebral compression fractures: An economic
analysis. Ont health Technol Assess Ser. 16:1–34. 2016.PubMed/NCBI
|
|
36
|
Peh WC and Gilula LA: Percutaneous
vertebroplasty: An update. Semin Ultrasound CT MR. 26:52–64.
2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wolman DN and Heit JJ: Recent advances in
vertebral augmentation for the treatment of vertebral body
compression fractures. Curr Phys Med Rehabilitation Rep. 5:1–14.
2017.
|
|
38
|
Wang H, Sribastav SS, Ye F, Yang C, Wang
J, Liu H and Zheng Z: Comparison of percutaneous vertebroplasty and
balloon kyphoplasty for the treatment of single level vertebral
compression fractures: A meta-analysis of the literature. Pain
Physician. 18:209–222. 2015.PubMed/NCBI
|
|
39
|
Chen L, Ni RF, Liu SY, Liu YZ, Jin YH, Zhu
XL, Zou JW and Xiao XS: Percutaneous vertebroplasty as a treatment
for painful osteoblastic metastatic spinal lesions. J Vasc Interv
Radiol. 22:525–528. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Calmels V, Vallee JN, Rose M and Chiras J:
Osteoblastic and mixed spinal metastases: evaluation of the
analgesic efficacy of percutaneous vertebroplasty. AJNR Am J
Neuroradiol. 28:570–574. 2007.PubMed/NCBI
|
|
41
|
Chen G, Luo ZP, Zhang H, Nalajala B and
Yang H: Percutaneous kyphoplasty in the treatment of painful
osteoblastic metastatic spinal lesions. J Clin Neurosci.
20:948–950. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mattei TA, Mendel E and Bourekas EC:
Vertebral compression fractures in patients under treatment with
denosumab: A contraindication for percutaneous vertebroplasty?
Spine J. 14:e29–e35. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chow E, Ding K, Parulekar WR, Wong RK, van
der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, et
al: Revisiting classification of pain from bone metastases as mild,
moderate, or severe based on correlation with function and quality
of life. Support Care Cancer. 24:1617–1623. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang Y, Liu H, Pi B, Yang H, Qian Z and
Zhu X: Clinical evaluation of percutaneous kyphoplasty in the
treatment of osteolytic and osteoblastic metastatic vertebral
lesions. Int J Surg. 30:161–165. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Costa L, Badia X, Chow E, Lipton A and
Wardley A: Impact of skeletal complications on patients' quality of
life, mobility, and functional independence. Support Care Cancer.
16:879–889. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bedard G, Zeng L, Poon M, Lam H, Lauzon N
and Chow E: Comparison of the EORTC QLQ-BM22 and the BOMET-QOL
quality of life questionnaires in patients with bone metastases.
Asia Pac J Clin Oncol. 10:118–123. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nieuwenhuijse MJ, Van Erkel AR and
Dijkstra PD: Cement leakage in percutaneous vertebroplasty for
osteoporotic vertebral compression fractures: Identification of
risk factors. Spine J. 11:839–848. 2011.PubMed/NCBI View Article : Google Scholar
|
